Last reviewed · How we verify

NCT02827305

Clinical Evaluation of the Centella Asiatica (Gotukola) Mouthwash as an Adjunct to Mechanical Plaque Control: A RCT

Completed Phase 1 Last updated 7 July 2016
What this trial tests

Phase 1 trial testing Gotukola in Gingival Diseases in 36 participants. Completed in 1 August 2015.

Timeline
1 August 2015
Primary endpoint
1 August 2015
1 August 2015

Quick facts

Lead sponsorSri Hasanamba Dental College and Hospital
PhasePhase 1
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment36
Start date1 August 2015
Primary completion1 August 2015
Estimated completion1 August 2015
Sites1 location across India

Drugs / interventions tested

Conditions studied

Sponsor

Sri Hasanamba Dental College and Hospital

Who can join

Adults 14 to 30, any sex, with Gingival Diseases. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

This study evaluates the adjunctive use of Centella Asiatica (gotukola) to scaling in the reduction of plaque and gingival inflammation. Patients were divided into three groups of which group 1 received scaling and gotukola mouthwash, group 2 received scaling only and group 3 received gotukola mouthwash only.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Gingival Diseases

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02827305.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing